Genetic Technologies Ltd (GENE)
Market Closed
14 Nov, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 77
0
0%
$
111.24M Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
$ 0.77
Previous Close Want to track GENE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GENE Earnings Reports FAQ
What is the earnings per share (EPS) for GENE?
The current EPS is 0.
What is the company's earnings growth rate?
Genetic Technologies Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Genetic Technologies Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Genetic Technologies Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GENE at this time, as Genetic Technologies Ltd has no recent EPS data to calculate it.
